Discover what DrugCard is and how it automates local medical literature screening for pharmacovigilance with AI-powered data intelligence.

DrugCard is a platform built to make drug safety routines smoother, with a focus on pharmacovigilance. It uses AI-powered data intelligence to support drug safety activities by automating tasks and improving efficiency. DrugCard lets you screen local medical literature continuously, regularly, transparently, in different languages, and cost-effectively, using natural language processing algorithms. It can process large volumes of scientific articles in various languages, and provides real-time notifications, detailed reports, and summaries of the literature it screens — useful for meeting regulatory requirements and keeping up with drug-related information.
DrugCard was created by DrugCard OÜ, a company focused on improving pharmacovigilance through AI-driven data intelligence. It offers services for screening local literature across multiple languages, automating the screening process to save time and resources while ensuring access to current information.
Compared to alternatives, DrugCard claims to discover 3–5 times more relevant findings, save 50–70% of screening time, and recognize keywords in scanned texts with 99% accuracy. The company also notes that building a similar system internally would take roughly a year for core features, plus another two years for platform development.
This workflow supports efficient local literature screening for pharmacovigilance and pharmaceutical research and development, while reducing manual work and resource requirements.
Related
Discover more tools in similar categories
Weekly picks of the best AI tools we've researched and added — no spam, unsubscribe anytime.
Join 25,000+ AI enthusiasts. No spam, unsubscribe anytime.